These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants. Granoff DM, Holmes SJ, Belshe RB, Osterholm MT, McHugh JE, Anderson EL. JAMA; 1994 Oct 12; 272(14):1116-21. PubMed ID: 7933324 [Abstract] [Full Text] [Related]
3. Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants. Anderson EL, Decker MD, Englund JA, Edwards KM, Anderson P, McInnes P, Belshe RB. JAMA; 1995 Mar 15; 273(11):849-53. PubMed ID: 7869554 [Abstract] [Full Text] [Related]
4. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period. Miller MA, Meschievitz CK, Ballanco GA, Daum RS. Pediatrics; 1995 Apr 15; 95(4):522-7. PubMed ID: 7700752 [Abstract] [Full Text] [Related]
9. Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines. Lieberman JM, Greenberg DP, Wong VK, Partridge S, Chang SJ, Chiu CY, Ward JI. J Pediatr; 1995 Feb 15; 126(2):198-205. PubMed ID: 7844665 [Abstract] [Full Text] [Related]
10. Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens. Lagos R, Valenzuela MT, Levine OS, Losonsky GA, Erazo A, Wasserman SS, Levine MM. Lancet; 1998 May 16; 351(9114):1472-6. PubMed ID: 9605803 [Abstract] [Full Text] [Related]
11. Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines. Granoff DM, Rathore MH, Holmes SJ, Granoff PD, Lucas AH. Vaccine; 1993 May 16; 11 Suppl 1():S46-51. PubMed ID: 8447176 [Abstract] [Full Text] [Related]
12. Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants. Lagos R, Kotloff K, Hoffenbach A, San Martin O, Abrego P, Ureta AM, Pines E, Blondeau C, Bailleux F, Levine MM. Pediatr Infect Dis J; 1998 Apr 16; 17(4):294-304. PubMed ID: 9576383 [Abstract] [Full Text] [Related]
13. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. Granoff DM, Anderson EL, Osterholm MT, Holmes SJ, McHugh JE, Belshe RB, Medley F, Murphy TV. J Pediatr; 1992 Aug 16; 121(2):187-94. PubMed ID: 1640282 [Abstract] [Full Text] [Related]
14. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants. Dashefsky B, Wald E, Guerra N, Byers C. Pediatrics; 1990 Apr 16; 85(4 Pt 2):682-9. PubMed ID: 2107519 [Abstract] [Full Text] [Related]
15. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. Shinefield HR, Black S, Ray P, Chang I, Lewis N, Fireman B, Hackell J, Paradiso PR, Siber G, Kohberger R, Madore DV, Malinowski FJ, Kimura A, Le C, Landaw I, Aguilar J, Hansen J. Pediatr Infect Dis J; 1999 Sep 16; 18(9):757-63. PubMed ID: 10493334 [Abstract] [Full Text] [Related]
16. Antibody response of Navajo children primed with PRP-OMP vaccine to booster doses of PRP-OMP vs. HbOC vaccine. Reid R, Santosham M, Croll J, Thompson C, Newcomer W, Siber GR. Pediatr Infect Dis J; 1993 Oct 16; 12(10):812-5. PubMed ID: 8284116 [Abstract] [Full Text] [Related]
17. Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections. Schmitt HJ, Knuf M, Ortiz E, Sänger R, Uwamwezi MC, Kaufhold A. J Pediatr; 2000 Sep 16; 137(3):304-12. PubMed ID: 10969252 [Abstract] [Full Text] [Related]
18. Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccine in infants. Holmes SJ, Fritzell B, Guito KP, Esbenshade JF, Blatter MM, Reisinger KS, Keyserling HL, Rothstein EP, Bernstein HH, Feldman S. Am J Dis Child; 1993 Aug 16; 147(8):832-6. PubMed ID: 8352217 [Abstract] [Full Text] [Related]
19. Response to a Haemophilus influenzae type b diphtheria CRM197 conjugate vaccine in children with a defect of antibody production to Haemophilus influenzae type b polysaccharide. Schneider LC, Insel RA, Howie G, Madore DV, Geha RS. J Allergy Clin Immunol; 1990 May 16; 85(5):948-53. PubMed ID: 2332568 [Abstract] [Full Text] [Related]
20. Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines. Rothstein EP, Schiller RP, Girone JA, Hipp TJ, Souder RL, Bernstein HH, Madore DV, Johnson CL, Smith DH. Am J Dis Child; 1991 Aug 16; 145(8):898-900. PubMed ID: 1858727 [Abstract] [Full Text] [Related] Page: [Next] [New Search]